FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcPYjd2 — IDRO (@IDROOhio) March 7, 2019
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant Depression - Forbes https://t.co/oeTWcPYjd2
No comments:
Post a Comment